169 related articles for article (PubMed ID: 34667024)
21. Adipogenesis induces growth inhibition of dedifferentiated liposarcoma.
Kim YJ; Yu DB; Kim M; Choi YL
Cancer Sci; 2019 Aug; 110(8):2676-2683. PubMed ID: 31069877
[TBL] [Abstract][Full Text] [Related]
22. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological and histopathological review of dedifferentiated liposarcoma: a comprehensive study of 123 primary tumours.
Mori T; Yamada Y; Kinoshita I; Kohashi K; Yamamoto H; Ito Y; Susuki Y; Kawaguchi K; Nakashima Y; Oda Y
Histopathology; 2022 Feb; 80(3):538-557. PubMed ID: 34699612
[TBL] [Abstract][Full Text] [Related]
24. Comparison between retroperitoneal leiomyosarcoma and dedifferentiated liposarcoma.
Ishii T; Kohashi K; Ootsuka H; Iura K; Maekawa A; Yamada Y; Bekki H; Yoshimoto M; Yamamoto H; Iwamoto Y; Oda Y
Pathol Res Pract; 2017 Jun; 213(6):634-638. PubMed ID: 28552535
[TBL] [Abstract][Full Text] [Related]
25. The CCAAT enhancer-binding protein-alpha negatively regulates the transactivation of androgen receptor in prostate cancer cells.
Chattopadhyay S; Gong EY; Hwang M; Park E; Lee HJ; Hong CY; Choi HS; Cheong JH; Kwon HB; Lee K
Mol Endocrinol; 2006 May; 20(5):984-95. PubMed ID: 16455820
[TBL] [Abstract][Full Text] [Related]
26. Heterogeneity and immunophenotypic plasticity of malignant cells in human liposarcomas.
Zhang Y; Young ED; Bill K; Belousov R; Peng T; Lazar AJ; Pollock RE; Simmons PJ; Lev D; Kolonin MG
Stem Cell Res; 2013 Sep; 11(2):772-81. PubMed ID: 23770802
[TBL] [Abstract][Full Text] [Related]
27. Anti-tumor activity of the MDM2-TP53 inhibitor BI-907828 in dedifferentiated liposarcoma patient-derived xenograft models harboring MDM2 amplification.
Cornillie J; Wozniak A; Li H; Gebreyohannes YK; Wellens J; Hompes D; Debiec-Rychter M; Sciot R; Schöffski P
Clin Transl Oncol; 2020 Apr; 22(4):546-554. PubMed ID: 31201607
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia regulates the expression and localization of CCAAT/enhancer binding protein α by hypoxia inducible factor-1α in bladder transitional carcinoma cells.
Xue M; Li X; Chen W
Mol Med Rep; 2015 Aug; 12(2):2121-7. PubMed ID: 25824695
[TBL] [Abstract][Full Text] [Related]
29. Progression-Free Survival Among Patients With Well-Differentiated or Dedifferentiated Liposarcoma Treated With CDK4 Inhibitor Palbociclib: A Phase 2 Clinical Trial.
Dickson MA; Schwartz GK; Keohan ML; D'Angelo SP; Gounder MM; Chi P; Antonescu CR; Landa J; Qin LX; Crago AM; Singer S; Koff A; Tap WD
JAMA Oncol; 2016 Jul; 2(7):937-40. PubMed ID: 27124835
[TBL] [Abstract][Full Text] [Related]
30. Dedifferentiated liposarcoma with rhabdomyoblastic differentiation.
Shimada S; Ishizawa T; Ishizawa K; Kamada K; Hirose T
Virchows Arch; 2005 Nov; 447(5):835-41. PubMed ID: 16012847
[TBL] [Abstract][Full Text] [Related]
31. Retroperitoneal liposarcomas: follow-up analysis of dedifferentiation after clinicopathologic reexamination of 86 liposarcomas and malignant fibrous histiocytomas.
Fabre-Guillevin E; Coindre JM; Somerhausen Nde S; Bonichon F; Stoeckle E; Bui NB
Cancer; 2006 Jun; 106(12):2725-33. PubMed ID: 16688768
[TBL] [Abstract][Full Text] [Related]
32. C/EBPα in normal and malignant myelopoiesis.
Friedman AD
Int J Hematol; 2015 Apr; 101(4):330-41. PubMed ID: 25753223
[TBL] [Abstract][Full Text] [Related]
33. Amplification of FRS2 in atypical lipomatous tumour/well-differentiated liposarcoma and de-differentiated liposarcoma: a clinicopathological and genetic study of 146 cases.
Jing W; Lan T; Chen H; Zhang Z; Chen M; Peng R; He X; Zhang H
Histopathology; 2018 Jun; 72(7):1145-1155. PubMed ID: 29368794
[TBL] [Abstract][Full Text] [Related]
34. Decreased activity and enhanced nuclear export of CCAAT-enhancer-binding protein beta during inhibition of adipogenesis by ceramide.
Sprott KM; Chumley MJ; Hanson JM; Dobrowsky RT
Biochem J; 2002 Jul; 365(Pt 1):181-91. PubMed ID: 12071851
[TBL] [Abstract][Full Text] [Related]
35. C/EBPalpha regulates SIRT1 expression during adipogenesis.
Jin Q; Zhang F; Yan T; Liu Z; Wang C; Ge X; Zhai Q
Cell Res; 2010 Apr; 20(4):470-9. PubMed ID: 20157332
[TBL] [Abstract][Full Text] [Related]
36. C/EBPalpha identifies differentiating preadipocytes around hair follicles in foetal and neonatal rat and mouse skin.
Wojciechowicz K; Markiewicz E; Jahoda CA
Exp Dermatol; 2008 Aug; 17(8):675-80. PubMed ID: 18328085
[TBL] [Abstract][Full Text] [Related]
37. A tumor suppressor role for C/EBPα in solid tumors: more than fat and blood.
Lourenço AR; Coffer PJ
Oncogene; 2017 Sep; 36(37):5221-5230. PubMed ID: 28504718
[TBL] [Abstract][Full Text] [Related]
38. Small RNA sequencing and functional characterization reveals MicroRNA-143 tumor suppressor activity in liposarcoma.
Ugras S; Brill E; Jacobsen A; Hafner M; Socci ND; Decarolis PL; Khanin R; O'Connor R; Mihailovic A; Taylor BS; Sheridan R; Gimble JM; Viale A; Crago A; Antonescu CR; Sander C; Tuschl T; Singer S
Cancer Res; 2011 Sep; 71(17):5659-69. PubMed ID: 21693658
[TBL] [Abstract][Full Text] [Related]
39. High amplification levels of MDM2 and CDK4 correlate with poor outcome in patients with dedifferentiated liposarcoma: A cytogenomic microarray analysis of 47 cases.
Ricciotti RW; Baraff AJ; Jour G; Kyriss M; Wu Y; Liu Y; Li SC; Hoch B; Liu YJ
Cancer Genet; 2017 Dec; 218-219():69-80. PubMed ID: 29153098
[TBL] [Abstract][Full Text] [Related]
40. Hyperglycemia Changes Expression of Key Adipogenesis Markers
Świderska E; Podolska M; Strycharz J; Szwed M; Abramczyk H; Brożek-Płuska B; Wróblewski A; Szemraj J; Majsterek I; Drzewoski J; Śliwińska A
Nutrients; 2019 Aug; 11(8):. PubMed ID: 31398873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
